- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00574002
Establishing Safe Drainage Limits for Pleural Chest Tube Removal.
January 5, 2017 updated by: University of Missouri, Kansas City
Defining the Threshold for Safe Chest Tube Removal.
The purpose of the study is to evaluate a safe threshold for when to remove chest tubes in patients based on the amount of drainage present.
Study Overview
Status
Withdrawn
Conditions
Detailed Description
Measurement of pleural fluid drainage in chest tubes of trauma patients.
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Truman Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Surgery patients
Description
Inclusion Criteria:
- Presence of at least one chest tube
- No air leak present
- Fluid is not infected
- Pleural drainage of fluid was an indication for placement of the chest tube
- Patient is post-thoracic surgery
- Patient is post-thoracic trauma
- Informed consent obtained
Exclusion Criteria:
- Presence of air leak
- Infected pleural fluid
- Active intra-thoracic bleeding
- Thoracic empyema
- Non-removal of chest tube (i.e.: expired)
- Pregnancy
- Less than 18 years of age
- Unable to obtain informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Group A
Patients that have their chest tube removed when drainage is 400mL or less in 24 hours.
|
|
Group B.
Patients that have their chest tube removed when drainage is 200mL or less in 24 hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Repeat chest tube insertion within 30 days
Time Frame: two years
|
two years
|
|
Thoracotomy on affected side within 30 days
Time Frame: Two years
|
Two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Gerald L. Early, M.D., M.A., Truman Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2007
Primary Completion (Actual)
November 1, 2009
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
December 12, 2007
First Submitted That Met QC Criteria
December 12, 2007
First Posted (Estimate)
December 14, 2007
Study Record Updates
Last Update Posted (Estimate)
January 9, 2017
Last Update Submitted That Met QC Criteria
January 5, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07-68e
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.